サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439260

経粘膜ドラッグデリバリーデバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Transmucosal Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
経粘膜ドラッグデリバリーデバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の経粘膜ドラッグデリバリーデバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 経粘膜ドラッグデリバリーデバイス市場レポートのイントロダクション

第2章 経粘膜ドラッグデリバリーデバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
  • 日本

第4章 経粘膜ドラッグデリバリーデバイス市場の主な要因の分析

  • 経粘膜ドラッグデリバリーデバイス市場の促進要因
  • 経粘膜ドラッグデリバリーデバイス市場の抑制要因と課題
  • 経粘膜ドラッグデリバリーデバイス市場の機会

第5章 経粘膜ドラッグデリバリーデバイスのポーターのファイブフォース分析

第6章 経粘膜ドラッグデリバリーデバイス市場に対するCOVID-19の影響の分析

第7章 経粘膜ドラッグデリバリーデバイス市場レイアウト

  • エンドユーザー別
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 経粘膜ドラッグデリバリーデバイス：世界の企業シェア分析 - 主要3～5社

第9章 経粘膜ドラッグデリバリーデバイスの企業と製品のプロファイル

第10章 プロジェクトのアプローチ

  • 二次資料
  • 一次資料
  • データの三角測量
  • 主な専門家の意見

第11章 KOLの見解

第12章 DelveInsightのサービス内容

第13章 免責事項

第14章 DelveInsightについて

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Transmucosal Drug Delivery Devices Market Analysis
  • Table 3 Transmucosal Drug Delivery Devices Market Analysis in Global (2021-2030)
  • Table 4 Transmucosal Drug Delivery Devices Market Analysis in Global by Segment 1 (2021-2030)
  • Table 5 Transmucosal Drug Delivery Devices Market Analysis in Global by Segment 2 (2021-2030)
  • Table 6 Transmucosal Drug Delivery Devices Market Analysis in Global by End User (2021-2030)
  • Table 7 Transmucosal Drug Delivery Devices Market Analysis in Global by Geography (2021-2030)
  • Table 8 Transmucosal Drug Delivery Devices Market Analysis in North America (2021-2030)
  • Table 9 Transmucosal Drug Delivery Devices Market Analysis in North America by Segment 1 (2021-2030)
  • Table 10 Transmucosal Drug Delivery Devices Market Analysis in North America by Segment 2 (2021-2030)
  • Table 11 Transmucosal Drug Delivery Devices Market Analysis in North America by End User (2021-2030)
  • Table 12 Transmucosal Drug Delivery Devices Market Analysis in North America by Country (2021-2030)
  • Table 13 Transmucosal Drug Delivery Devices Market Analysis in the US (2021-2030)
  • Table 14 Transmucosal Drug Delivery Devices Market Analysis in Canada (2021-2030)
  • Table 15 Transmucosal Drug Delivery Devices Market Analysis in Mexico (2021-2030)
  • Table 16 Transmucosal Drug Delivery Devices Market Analysis in Europe (2021-2030)
  • Table 17 Transmucosal Drug Delivery Devices Market Analysis in Europe by Segment 1 (2021-2030)
  • Table 18 Transmucosal Drug Delivery Devices Market Analysis in Europe by Segment 2 (2021-2030)
  • Table 19 Transmucosal Drug Delivery Devices Market Analysis in Europe by End User (2021-2030)
  • Table 20 Transmucosal Drug Delivery Devices Market Analysis in Europe by Country (2021-2030)
  • Table 21 Transmucosal Drug Delivery Devices Market Analysis in France (2021-2030)
  • Table 22 Transmucosal Drug Delivery Devices Market Analysis in Germany (2021-2030)
  • Table 23 Transmucosal Drug Delivery Devices Market Analysis in the UK (2021-2030)
  • Table 24 Transmucosal Drug Delivery Devices Market Analysis in Italy (2021-2030)
  • Table 25 Transmucosal Drug Delivery Devices Market Analysis in Spain (2021-2030)
  • Table 26 Transmucosal Drug Delivery Devices Market Analysis in Russia (2021-2030)
  • Table 27 Transmucosal Drug Delivery Devices Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Segment 1 (2021-2030)
  • Table 30 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Segment 2 (2021-2030)
  • Table 31 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Transmucosal Drug Delivery Devices Market Analysis in China (2021-2030)
  • Table 34 Transmucosal Drug Delivery Devices Market Analysis in Japan (2021-2030)
  • Table 35 Transmucosal Drug Delivery Devices Market Analysis in India (2021-2030)
  • Table 36 Transmucosal Drug Delivery Devices Market Analysis in Australia (2021-2030)
  • Table 37 Transmucosal Drug Delivery Devices Market Analysis in South Korea (2021-2030)
  • Table 38 Transmucosal Drug Delivery Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Transmucosal Drug Delivery Devices Market Analysis in Rest of World (2021-2030)
  • Table 40 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Segment 1 (2021-2030)
  • Table 41 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Segment 2 (2021-2030)
  • Table 42 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Transmucosal Drug Delivery Devices Market Analysis in Middle East (2021-2030)
  • Table 45 Transmucosal Drug Delivery Devices Market Analysis in Africa (2021-2030)
  • Table 46 Transmucosal Drug Delivery Devices Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Transmucosal Drug Delivery Devices Market Analysis
  • Figure 3 Transmucosal Drug Delivery Devices Market Analysis in Global (2021-2030)
  • Figure 4 Transmucosal Drug Delivery Devices Market Analysis in Global by Segment 1 (2021-2030)
  • Figure 5 Transmucosal Drug Delivery Devices Market Analysis in Global by Segment 2 (2021-2030)
  • Figure 6 Transmucosal Drug Delivery Devices Market Analysis in Global by End User (2021-2030)
  • Figure 7 Transmucosal Drug Delivery Devices Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Transmucosal Drug Delivery Devices Market Analysis in North America (2021-2030)
  • Figure 9 Transmucosal Drug Delivery Devices Market Analysis in North America by Segment 1 (2021-2030)
  • Figure 10 Transmucosal Drug Delivery Devices Market Analysis in North America by Segment 2 (2021-2030)
  • Figure 11 Transmucosal Drug Delivery Devices Market Analysis in North America by End User (2021-2030)
  • Figure 12 Transmucosal Drug Delivery Devices Market Analysis in North America by Country (2021-2030)
  • Figure 13 Transmucosal Drug Delivery Devices Market Analysis in the US (2021-2030)
  • Figure 14 Transmucosal Drug Delivery Devices Market Analysis in Canada (2021-2030)
  • Figure 15 Transmucosal Drug Delivery Devices Market Analysis in Mexico (2021-2030)
  • Figure 16 Transmucosal Drug Delivery Devices Market Analysis in Europe (2021-2030)
  • Figure 17 Transmucosal Drug Delivery Devices Market Analysis in Europe by Segment 1 (2021-2030)
  • Figure 18 Transmucosal Drug Delivery Devices Market Analysis in Europe by Segment 2 (2021-2030)
  • Figure 19 Transmucosal Drug Delivery Devices Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Transmucosal Drug Delivery Devices Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Transmucosal Drug Delivery Devices Market Analysis in France (2021-2030)
  • Figure 22 Transmucosal Drug Delivery Devices Market Analysis in Germany (2021-2030)
  • Figure 23 Transmucosal Drug Delivery Devices Market Analysis in the UK (2021-2030)
  • Figure 24 Transmucosal Drug Delivery Devices Market Analysis in Italy (2021-2030)
  • Figure 25 Transmucosal Drug Delivery Devices Market Analysis in Spain (2021-2030)
  • Figure 26 Transmucosal Drug Delivery Devices Market Analysis in Russia (2021-2030)
  • Figure 27 Transmucosal Drug Delivery Devices Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Segment 1 (2021-2030)
  • Figure 30 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Segment 2 (2021-2030)
  • Figure 31 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Transmucosal Drug Delivery Devices Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Transmucosal Drug Delivery Devices Market Analysis in China (2021-2030)
  • Figure 34 Transmucosal Drug Delivery Devices Market Analysis in Japan (2021-2030)
  • Figure 35 Transmucosal Drug Delivery Devices Market Analysis in India (2021-2030)
  • Figure 36 Transmucosal Drug Delivery Devices Market Analysis in Australia (2021-2030)
  • Figure 37 Transmucosal Drug Delivery Devices Market Analysis in South Korea (2021-2030)
  • Figure 38 Transmucosal Drug Delivery Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Transmucosal Drug Delivery Devices Market Analysis in Rest of World (2021-2030)
  • Figure 40 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Segment 1 (2021-2030)
  • Figure 41 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Segment 2 (2021-2030)
  • Figure 42 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Transmucosal Drug Delivery Devices Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Transmucosal Drug Delivery Devices Market Analysis in Middle East (2021-2030)
  • Figure 45 Transmucosal Drug Delivery Devices Market Analysis in Africa (2021-2030)
  • Figure 46 Transmucosal Drug Delivery Devices Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0049

DelveInsight's 'Transmucosal Drug Delivery Devices - Market Insight, Competitive Landscape, and Market Forecast - 2030' report delivers an in-depth understanding of Transmucosal Drug Delivery Devices and the historical and forecasted Transmucosal Drug Delivery Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

The Transmucosal Drug Delivery Devices market report provides an overview of Transmucosal Drug Delivery Devices , applications of Transmucosal Drug Delivery Devices as well as its advantages and limitations. Additionally, the report provides insight on the Transmucosal Drug Delivery Devices market share by segments, along with assessment of market share by regions, the qualitative and quantitative (USD million, 2021-2030) data will be provided for all the segment in the scope. Moreover, the report also covers the market drivers, market challenges and restraints, and opportunities, along with the impact COVID-19 has had on this market. Assessment of Key 12-15 Players operating in the Transmucosal Drug Delivery Devices market will be covered in-depth in the report comprising of company overview, financial overview, product overview and company share analysis of key 3-5 players. Additionally the PORTER's analysis will also be provided to give an analytical edge to the Transmucosal Drug Delivery Devices market report.

Study Period: 2021-2030

Geography Covered

North America

The United States

Canada

Mexico

Europe

Germany

France

Italy

Spain

The United Kingdom

Russia

Rest of Europe

Asia Pacific

Japan

China

India

South Korea

Australia

Rest of APAC

RoW

Middle East

Africa

South America

Transmucosal Drug Delivery Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Transmucosal Drug Delivery Devices , to help understand the competition in the market. It gives a comparative understanding of the Key Companies in the market.

Transmucosal Drug Delivery Devices : Market Analysis

This segment illustrates the global market of Transmucosal Drug Delivery Devices along with the market segmentation. Furthermore, the Transmucosal Drug Delivery Devices market report will provide the regional level cross-segmentation quantitative data. Moreover, the assessment is done on how the market is expected to rise in the study period (2021 to 2030), at a significant CAGR.

KOL- Views

To keep up with the market trends, we take KOLs and SME's opinion working in Transmucosal Drug Delivery Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging Transmucosal Drug Delivery Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

The report covers the descriptive overview of Transmucosal Drug Delivery Devices , explaining its applications, advantages, and limitations, etc.

Additionally, detailed profiles of the Key Companies operating in the market is provided, along with the market share of the Key 3-5 players.

A detailed review of Transmucosal Drug Delivery Devices market; historical and forecasted market size is included in the report, covering global outreach.

The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Transmucosal Drug Delivery Devices market.

Report Highlights

The report also reviews the detailed global historical and forecasted Transmucosal Drug Delivery Devices market including assessing the outreach in America, Europe, APAC, and Rest of World (RoW).

The report helps in developing business strategies by understanding trends shaping and driving the global Transmucosal Drug Delivery Devices market.

The impact of COVID-19 on the Transmucosal Drug Delivery Devices market will be discussed in detail in the report.

Transmucosal Drug Delivery Devices Report Key Strengths

5 Years Forecast

Global Coverage

Competitive Landscape

Transmucosal Drug Delivery Devices Market Size

Transmucosal Drug Delivery Devices Market Segmentation

Transmucosal Drug Delivery Devices Market Company Profiles

Transmucosal Drug Delivery Devices Market PORTER's Five Forces Analysis

Transmucosal Drug Delivery Devices Market Company Share Analysis (Key 3-4 players)

Transmucosal Drug Delivery Devices Report Assessment

Marketed Product profiles

Key Products and Key Players

Market Drivers and Barriers

Market Forecast

KOL'S views

Key Takeaways from the Transmucosal Drug Delivery Devices Market Report Study

Transmucosal Drug Delivery Devices Market size analysis for current market (2023), and Transmucosal Drug Delivery Devices market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on Transmucosal Drug Delivery Devices market is significant. To capture and analyze suitable indicators, our experts are closely watching the Transmucosal Drug Delivery Devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years in Transmucosal Drug Delivery Devices market.

Key companies dominating the Global Transmucosal Drug Delivery Devices Market.

Various opportunities available for the other competitor in the Transmucosal Drug Delivery Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current Transmucosal Drug Delivery Devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Transmucosal Drug Delivery Devices market growth in the coming future?

Target Audience who can benefit from Transmucosal Drug Delivery Devices Market Report Study

Transmucosal Drug Delivery Devices providers

Research organizations and consulting companies

Transmucosal Drug Delivery Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Transmucosal Drug Delivery Devices market

Various End-users who want to know more about the Transmucosal Drug Delivery Devices Market and latest technological developments in the Transmucosal Drug Delivery Devices market.

Table of Contents

1 Transmucosal Drug Delivery Devices Market Report Introduction

2 Transmucosal Drug Delivery Devices Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3 Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 Italy
    • 3.2.4 Spain
    • 3.2.5 U.K.
  • 3.3 Japan

4 Transmucosal Drug Delivery Devices Market Key factors analysis

  • 4.1 Transmucosal Drug Delivery Devices Market Drivers
    • 4.1.1 Driver 1
    • 4.1.2 Driver 2
    • 4.1.3 Driver 3
  • 4.2 Transmucosal Drug Delivery Devices Market Restraints and Challenges
    • 4.2.1 Restraints and Challenges 1
    • 4.2.2 Restraints and Challenges 2
  • 4.3 Transmucosal Drug Delivery Devices Market Opportunities
    • 4.3.1 Market Opportunity 1
    • 4.3.2 Market Opportunity 2

5 Transmucosal Drug Delivery Devices Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6 COVID-19 Impact Analysis on Transmucosal Drug Delivery Devices Market

7 Transmucosal Drug Delivery Devices Market layout

  • 7.1 Segment 1
  • 7.2 Segment 2
  • 7.3 By End User
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Transmucosal Drug Delivery Devices Market, by Segment 1
      • 7.4.1.2 North America Transmucosal Drug Delivery Devices Market, by Segment 2
      • 7.4.1.3 North America Transmucosal Drug Delivery Devices Market, by End User
      • 7.4.1.4 North America Transmucosal Drug Delivery Devices Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Transmucosal Drug Delivery Devices Market, by Segment 1
      • 7.4.2.2 Europe Transmucosal Drug Delivery Devices Market, by Segment 2
      • 7.4.2.3 Europe Transmucosal Drug Delivery Devices Market, by End User
      • 7.4.2.4 Europe Transmucosal Drug Delivery Devices Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Transmucosal Drug Delivery Devices Market, by Segment 1
      • 7.4.3.2 Asia-Pacific Transmucosal Drug Delivery Devices Market, by Segment 2
      • 7.4.3.3 Asia-Pacific Transmucosal Drug Delivery Devices Market, by End User
      • 7.4.3.4 Asia-Pacific Transmucosal Drug Delivery Devices Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Transmucosal Drug Delivery Devices Market, by Segment 1
      • 7.4.4.2 RoW Transmucosal Drug Delivery Devices Market, by Segment 2
      • 7.4.4.3 RoW Transmucosal Drug Delivery Devices Market, by End User
      • 7.4.4.4 RoW Transmucosal Drug Delivery Devices Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8 Transmucosal Drug Delivery Devices Global Company Share Analysis - Key 3-5 Companies

9 Transmucosal Drug Delivery Devices Company and Product Profiles

  • 9.1 Company 1
    • 9.1.1 Company Overview
    • 9.1.2 Company Snapshot
    • 9.1.3 Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5 Entropy
  • 9.2 Company 2
    • 9.2.1 Company Overview
    • 9.2.2 Company Snapshot
    • 9.2.3 Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5 Entropy
  • 9.3 Company 3
    • 9.3.1 Company Overview
    • 9.3.2 Company Snapshot
    • 9.3.3 Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5 Entropy
  • 9.4 Company 4
    • 9.4.1 Company Overview
    • 9.4.2 Company Snapshot
    • 9.4.3 Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5 Entropy
  • 9.5 Company 5
    • 9.5.1 Company Overview
    • 9.5.2 Company Snapshot
    • 9.5.3 Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5 Entropy

More companies will be provided in final coverage..

10 PROJECT APPROACH

  • 10.1 Secondary Sources
  • 10.2 Primary Sources
  • 10.3 Data Triangulation
  • 10.4 Key Expert Opinions

11 KOL Views

12 DelveInsight Capabilities

13 Disclaimer

14 About DelveInsight